Suramin Sodium (PaxMedica)

苏拉明钠 (PaxMedica)

Report date: 2026/03/15 20:00:14

Base Information

Drug NameSuramin Sodium (PaxMedica)
Drug Alias NamePAX-101PAX-102
ClassificationSmall molecules
Mechanisms of ActionHeparanase inhibitors
TargetsHeparanase
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKuvatris Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuvatris Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutism Spectrum Disorder

Other Information

ATC CodeN/A
Related LinksN/A